Drugs that help women reduce their risk of breast cancer can carry other health risks, according to researchers who analyzed multiple studies. Tamoxifen reduces the risk of recurrence with ER-positive breast cancer but increases chances for a more aggressive type of the disease, while both tamoxifen and raloxifene significantly raise the risk of blood clots.

Full Story:

Related Summaries